Previous 10 | Next 10 |
Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Divi...
Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Divi...
Summary Summers Value Partners is a boutique value manager that uses a focused, long-term approach to investing in areas of the market where most managers are unwilling or unable to participate. The Summers Value Fund LP (“the Fund”) returned -25.9% net in the first ...
Utah Medical Products press release ( NASDAQ: UTMD ): Q2 GAAP EPS of $1.12. Revenue of $13.4M (+6.3% Y/Y). For further details see: Utah Medical Products GAAP EPS of $1.12, revenue of $13.4M
SALT LAKE CITY, UT - ( NewMediaWire ) - July 26, 2022 - UTMD achieved second calendar quarter (2Q) and first half (1H) 2022 financial results better than those anticipated in its beginning of year projections. Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia ...
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The Dividend Champions list is a monthly...
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend Champion, Contender, An...
Utah Medical Products (NASDAQ:UTMD) declares $0.29/share quarterly dividend, in line with previous. Forward yield 1.39% Payable July 6; for shareholders of record June 17; ex-div June 16. See UTMD Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: Utah Medi...
Utah Medical Products press release (NASDAQ:UTMD): Q1 GAAP EPS of $0.964. Revenue of $12.32M (+12.4% Y/Y). For further details see: Utah Medical Products GAAP EPS of $0.964, revenue of $12.32M
SALT LAKE CITY, UT, April 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – In the first calendar quarter (1Q) of 2022, Utah Medical Products, Inc. (Nasdaq: UTMD) attained financial results consistent with achieving its goals for calendar year 2022. Summary of results . ...
News, Short Squeeze, Breakout and More Instantly...
Utah Medical Products Inc. Company Name:
UTMD Stock Symbol:
NASDAQ Market:
Utah Medical Products Inc. Website:
2024-06-25 08:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SALT LAKE CITY, UT / ACCESSWIRE / April 25, 2024 / In the first calendar quarter (1Q) of 2024, Utah Medical Products, Inc. (NASDAQ:UTMD) attained financial results consistent with its previously announced projections for calendar year 2024. Summary of results . The following is a summary com...
Kiniksa Pharmaceuticals Ltd. (KNSA) is expected to report $-0.14 for Q1 2024 Agree Realty Corporation (ADC) is expected to report $1.01 for Q1 2024 1st Colonial Bancorp Inc (FCOB) is expected to report for Q1 2024 Equity Residential of Beneficial Interest (EQR) is expected to report $...